Navigation Links
Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering Europe
Date:10/7/2009

CALGARY, Oct. 7 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 17th Annual BioPartnering Europe conference in London, U.K. on Monday, October 12 at 10:15 a.m. The conference is taking place at the Queen Elizabeth II Conference Centre from October 11-13, 2009.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN(R), its proprietary formulation of the human reovirus. For further information about Oncolytics, please visit: www.oncolyticsbiotech.com.

The presentation time is subject to change. This release and the presentation related thereto contain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control and which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or expectations implied by these forward-looking statements. Such risks and uncertainties include, among others, the efficacy of REOLYSIN as a cancer treatment, the success and timely completion of clinical studies and trials, uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against pla
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. InVitrias Better Ingredients for Better Media to be Showcased at BPI 09
2. Advanced Health Media Named to 2009 InformationWeek 500 List of Top Technology Innovators Across America
3. Cadient Group Selected as Finalist in Medical Marketing & Media Awards
4. Media Advisory - Oncolytics Biotech Inc. to Present at Rodman Renshaw 11th Annual Healthcare Conference
5. Cell Metabolism Publishes Novel TGR5-Mediated Mechanism for the Treatment of Diabetes and Obesity
6. DeSilva + Phillips, Mediabankers, names Jim Brennan to Head Healthcare IT M&A Practice
7. BloodStor(TM) Stem Cell Biopreservation Media Platform Launched by BioLife Solutions
8. Bio-enabled, surface-mediated approach produces nanoparticle composites
9. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
10. Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit
11. BioLife Solutions Announces Validation and Start-Up of New Internal Manufacturing Facility for Serum-Free Cell and Tissue Biopreservation Media Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... (PRWEB) August 20, 2014 Not long ... E&L studies should be performed late in the development ... known. But current regulatory trends suggest that, like many ... the rise. In recent years, multiple drug sponsors have ... or address specific questions during phase I/II. It’s not ...
(Date:8/20/2014)... Aug. 20, 2014 /PRNewswire-iReach/ -- A case study ... between the school,s bioengineering department and the Intel® ... Intel® Software Academic Program, UCSD,s research focuses on ... human body.  Photo - ... the work of Dr. Todd P. Coleman ...
(Date:8/20/2014)... improve the health of your heart, researchers have discovered. ... a standard TENS machine like those designed to relieve ... the small raised flap at the front of the ... The stimulation changed the influence of the nervous system ... can drive failing hearts too hard. , Professor Jim ...
(Date:8/20/2014)... WriteResult®, a leading provider of Electronic Patient ... its myPROpad™ ePRO tablet with the addition of a ... most widely used and well-respected Patient Reported Outcome (PRO) ... is used during clinical trials and in other health ... used to demonstrate Health-Related Quality of Life outcomes (HRQoL) ...
Breaking Biology Technology:Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2'Tickling' your ear could be good for your heart 2EQ-5D™ Assessment Now Available for iPad 2
... Calif., Nov. 26 NeurogesX, Inc.,(Nasdaq: NGSX ... management therapies, announced today that it is scheduled ... Lazard Capital Markets Healthcare,Conference in New York City. ... presenting and Stephen Ghiglieri, Chief Financial Officer,will be ...
... Nov. 26 Archer Daniels Midland,Company (NYSE: ... vice,president, has elected to retire by year end., ... special assignment to advance the,Company,s business strategy for ... to the Company,s strategic planning group,under the direction ...
... (Amex:,SGN - News) has received FDA 510(k) clearance ... ambulatory event recorder throughout the United States.,This device, ... HeartLife,Tempo Card, is a direct-to-consumer non-prescription flexible credit ... as an early-detection,device by patients who desire to ...
Cached Biology Technology:NeurogesX to Present at Lazard Capital Markets Healthcare Conference 2NeurogesX to Present at Lazard Capital Markets Healthcare Conference 3ADM Executive Vice President Bill Camp to Retire 2Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device 2Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device 3
(Date:8/20/2014)... Women who are poor experience higher cortisol levels in ... of the stress hormone, putting them at greater ... a new research from the University of Colorado Denver. ... American Journal of Human Biology , is the first ... to the socioeconomic status of their mothers during pregnancy. ...
(Date:8/20/2014)... developed by researchers at the University of Missouri School ... a life-threatening heart condition caused by muscular dystrophy. ... Lai, Ph.D., the leading author of the study and ... Department of Molecular Microbiology and Immunology. "This is just ... to a treatment for people with this devastating heart ...
(Date:8/20/2014)... grows to about 4,000 members, it triggers an important ... a special type of comb used for rearing male ... Department of Neurobiology and Behaviour at Cornell University, led ... of honeybee colonies. The results are published in Springer,s ... , Reproduction isn,t always a honeybee colony,s top ...
Breaking Biology News(10 mins):CU Denver researcher shows economic disparities impact infant health 2Gene therapy protects mice from lethal heart condition, MU researchers find 2Worker bees 'know' when to invest in their reproductive future 2
... reaction (PCR) is a common technique used to amplify, or ... in genetic analyses for everything from medicine to forensics. ... and sequencing genes, and its applications are endless. However, ... the University of Southern Mississippi discovered that the use of ...
... an embryonic stem cell is in the first stage of ... type of cell in the body, a state scientists call ... a way to easily distinguish undifferentiated embryonic stem cells from ... published in the American Institute of Physics, (AIP) journal ...
... apply for press credentials for the American Chemical Society,s ... conferences of the New Year will be held April 7-11, ... than 13,000 scientists and others expected to gather in the ... span science,s horizons from astronomy to zoology ― the ...
Cached Biology News:Improving DNA amplification from problematic plants 2Press registration opens for 2013 meeting of world's largest scientific society 2
... KitTM allows graphic manipulation of DNA sequences ... an award winning interface design that allows ... to providing sophisticated drawing capabilities for Mac ... "Best Plasmid Mapping Software" by the Biotechnology ...
... ISO 9001:2000 Certified USDA Research Registered OLAW ... Training AALAS Certified Technicians ... GLP Documentation Upon Request Focus ... for all your custom immunology service needs. ...
... Quality ISO 9001:2000 Certified ... All Precedures Validated, SOP's Training ... Process for All Procedures GLP Documentation Upon ... one stop shopping point for all your ...
...
Biology Products: